Atomoxetine (Strattera)
Atomoxetine (Strattera) explained
Atomoxetine (Strattera) is a non‑stimulant selective norepinephrine reuptake inhibitor for ADHD, useful when stimulants aren’t tolerated or are contraindicated.
FDA ApprovedAtomoxetine (Strattera) helps treat
• Attention‑deficit/hyperactivity disorder (ADHD)
additional medications
• Guanfacine ER/clonidine ER
• Behavioral therapy
• Stimulants (methylphenidate or amphetamines)
medication risks
• Suicidality warning (boxed)
• Rare severe liver injury
• BP/HR increases
• Urinary retention (rare)
side effects
• Decreased appetite
• Nausea
• Fatigue/somnolence
• Dry mouth
• Dizziness
FAQs
Q: How is atomoxetine different?A: Non‑stimulant; lower abuse risk but slower onset than stimulants.
Q: How long to work?
A: Often 2–4+ weeks; full response may take longer.
Q: Any liver issues?
A: Rare severe liver injury—report jaundice/dark urine.
Q: Suicidality warning?
A: Yes—monitor mood, especially early in treatment.
Q: Dosing schedule?
A: Typically once or twice daily; consistent timing helps.
